The serotonin-2A receptor polymorphism and clinical symptoms in mood disorders, schizophrenia and alcohol dependence in Japan

Acta Neuropsychiatrica

Volumn 15, Issue 3, 2003, Pages 129-132

  Terayama, Hayato ^a,c,d   Takimoto, Takahiro ^a   Fukunishi, Isao ^b   Itoh, Masahiro ^c   Iwahashi, Kazuhiko ^a  

^a AZABU UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

^d Azabu University   (Japan)

Author keywords

5 HTR2A; Alcohol dependence; Linkage; Mood disorders; Schizophrenia

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; NEUROLEPTIC AGENT; SEROTONIN 2A RECEPTOR;

ADULT; ALCOHOLISM; ARTICLE; DRUG EFFECT; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PATHOGENESIS; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; PSYCHOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SCHIZOPHRENIA; SYMPTOMATOLOGY;

EID: 0037981273     PISSN: 09242708     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1601-5215.2003.00024.x     Document Type: Article

References (26)

1. KROEZE WK, ROTH BL. The molecular biology of serotonin receptors, therapeutic implications for the interface of mood and psychosis. Biol Psychiatry 1998;44:1128-1142.
2. HOYER D, CLARKE DE, FOZARD JR. International Union of Pharmacology Classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 1994;46:158-193.
3. 2A receptors, a review of in vivo studies. Behav Brain Res 1996;73:177-181.
4. 2A receptors in antipsychotic activity. Life Sci 1995;56:2209-2222.
5. LAI H, PRATHER PL, REZAZADEH SM. Potential role of 5HT1C and/or 5HT2 receptors in the mianserin-induced prevention of anxiogenic behaviors occurring during ethanol withdrawal. Alcohol Clin Exp Res 1993;17:411-417.
6. WARREN JT JR, PEACOCK ML, RODRIGUEZ LC, FINK JK. An MspI polymorphism in the hyman serotonin receptor gene (HTR2). detection by DGGE and RFLP analysis. Hum Mol Genet 1993;2:338.
7. 2A receptor gene and bipolar affective disorder. Hum Genet 1997;100:582-584.
8. KAY SR, FISZBEIN A, OPLER LR. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-276.
9. COLLIER AD, ARRANZ JM, LI T, MUPITA D, BROWN N, TREASURE J. Association between 5-HT2A gene promoter polymorphism and anorexia nervosa. Lancet 1997;350:412.
10. ENOCH MA, GOLDMAN D, BARNETT R, SHER L, MAZZANTI CM, ROSENTHAL NE. Association between seasonal affective disorder and the 5-HT2A promoter polymorphism-1438G/A. Mol Psychiatry 1999;4:89-92.
11. HIMEI A, KONO Y, YONEDA H, SAKAI T, KOH J, SAKAI J, INADA Y, IMAMICHI H. An association study between alcoholism and the serotonergic receptor genes. Alcohol Clin Exp Res 2000;24:341-342.
12. INAYAMA Y, YONEDA H, SAKAI T, ISHIDA T, NONOMURA Y, KONO Y, TAKAHATA R, KOH J, SAKAI J, TAKAI A, INADA Y, ASABA H. Positive association between a DNA sequence variant in the serotonin 2A receptor gene and schizophrenia. Am J Med Genet 1996;67:103-105.
13. OHARA K, INO A, ISHIGAKI T, TANI K, TSUKAMOTO T, NAKAMURA Y, OHARA K. Analysis of the 5′-flanking promoter region of the 5-HT2A receptor gene in schizophrenia. Neuropsychopharmacology 1997;17:274-278.
14. OHARA K, NAGAI M, TSUKAMOTO T, TANI K, SUZUKI Y, OHARA K. 5-HT2A receptor gene promoter polymorphism - 1438G/A and mood disorders. Neuroreport 1998;9:1139-1141.
15. SHINKAI T, OHMORI O, KOJIMA H, TERAO T, SUZUKI T, ABE K. Negative association between T102C polymorphism of the 5-HT2a receptor gene and schizophrenia in Japan. Hum Hered 1998;48:212-215.
16. KANE JM. Risperidone. new horizons for the schizophrenic patient. J Clin Psychiatry 1994;55:5.
17. ARRANZ M, COLLIER D, SODHI M et al. Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet 1995;29:281-282.
18. NIMGAONKAR VL, ZHANG XR, BRAR JS, DELEO M, GENGULI R. 5HT2 receptor gene locus: association with schizophrenia or treatment response not detected. Psychiatr Genet 1996;6:23-27.
19. WILLIAMS J, SPURLOCK G, McGUFFIN P et al. Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. Lancet 1996;347:1294-1296.
20. MITA T, HANADA S, NISHINO N et al. Decreased serotonin S2 and increased dopamine D2 receptor in chronic schizophrenics. Biol Psychiatry 1986;21: 1407-1414.
21. LARUELLE M, ABI-DARGHAM A, CASANOVA MF, TOTI R, WEINBERGER DR, KLEINMAN JE. Selective abnormalities of prefrontal serotonergic receptors in schizophrenia: a postmortem study. Arc General Psychiatry 1993;50: 810-818.
22. 2 receptor binding on blood platelets - a peripheral marker for depression? Life Sci 1987;41:2485-2492.
23. 2+ response is increased in the blood platelets of depressed patients. Biol Psychiatry 1991;30:310.
24. 2 and β-adrenergic receptor binding sites in the brain of suicide victims. Arch General Psychiatry 1997;47: 1038-1047.
25. CROW TJ. Molecular pathology of schizophrenia more than one disease process. Br Medical J 1980;1:66-68.
26. ANDREASEN NC. Negative symptoms in schizophrenia definition and reliability. Arch General Psychiatry 1982;39:784-788.